AI investment continues to drive chip shortage - marketplace.org
<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxQeHc5d3NhbEMwTlItSUpESHNOSmpLeVlIM2tmbnkwRFVSSHVhaXNsOVB0eHlGVXpuRzhScG8wYXI3eUVIN2FBaldNajJJakJTdHJTMU1PR0hfTGlrZHY4Sk1NTGVwUzBtUlViV1B1bWJSUHU0aE1ZM0Jyc2d0VEtLbFVTY3FqTzRlNkE?oc=5" target="_blank">AI investment continues to drive chip shortage</a> <font color="#6f6f6f">marketplace.org</font>
Could not retrieve the full article text.
Read on GNews AI chips →Sign in to highlight and annotate this article

Conversation starters
Daily AI Digest
Get the top 5 AI stories delivered to your inbox every morning.
More about
investmentmarket
Trump administration announces new tariffs on drugmakers
The Trump administration said on Thursday that it would impose 100% tariffs on patented pharmaceuticals to force deals for lower drug prices and move manufacturing to America. Why it matters: It is the latest example of President Trump using tariffs as leverage over corporate America. Zoom in : The threat of tariffs, which has hung over the pharmaceutical industry for months, helped drive 13 drug companies to make "most-favored nation" pricing deals with the White House late last year. It is possible that more companies will strike these voluntary pricing deals with the administration, and the new tariff announcement could be further motivation to do so to be exempted. The new tariffs could also spark a wave of industry announcements about domestic manufacturing investments. Zoom in: A sen
Knowledge Map
Connected Articles — Knowledge Graph
This article is connected to other articles through shared AI topics and tags.
More in Market News

Elon Musk is about to be a very busy boy!
To be honest, I thought Elon Musk would confidentially file for SpaceX's IPO on the 20th of this month, rather than the 1st. But maybe that just means he's moved on to other numbers, and we should all mark our calendars for June 7th as an IPO date just in case. Based on the April [ ]







Discussion
Sign in to join the discussion
No comments yet — be the first to share your thoughts!